 |
|
BRI Cancer Research Center  | | | | At Brigham and Women’s Hospital's Biomedical Research Institute (BRI), more than 160 principal investigators—with more than 200 funded grants—investigate cancer-related questions. Working in proximate laboratories and at scientific retreats, BWH researchers and physicians bring their collective expertise to bear on pressing questions that may enhance our knowledge of cancer prevention, develop and implement new cancer therapies, or improve existing cancer treatments. Working side by side, investigators in the BWH-BRI Cancer Research Center are uniquely positioned to facilitate the transfer of their most promising findings to patients at BWH. More>> | Featured BWH-BRI Cancer Investigators
BWH-BRI Cancer Research Center investigators have advanced and contributed insights to the world-wide community of scientists, physicians, policy makers, and the general public. The following profiles feature some of the leaders in cancer research at BWH. |  Dr. Stephen Blacklow studies cell surface receptors involved in a wide variety of disorders, including heart disease and cancer, with a goal of providing new opportunities for the development of targeted therapies.
| | 
| Dr. Charles Dimitroff and his team illuminate how immune cells travel to inflamed skin and how prostate tumor cells form secondary tumors in other parts of the body.
October 2009 Press Release: Researchers Identify Structure Aiding in Prostate Cancer Metastasis in Bone | | |  Dr. Jeffrey Parvin studies the function of a tumor suppressor protein called BRCA1 (breast cancer-1), which plays an important role in breast and ovarian cancers.
|  Dr. Fred Wang's research concerns the pathogenesis of Epstein-Barr Virus (EBV) infection: how it successfully infects humans, how it persists in humans, and how and why it is associated with certain kinds of cancer.
|
|
|
|
 |
